Inflammation and Immune Response in COPD: Where Do We Stand?
Tóm tắt
Increasing evidence indicates that chronic inflammatory and immune responses play key roles in the development and progression of COPD. Recent data provide evidence for a role in the NLRP3 inflammasome in the airway inflammation observed in COPD. Cigarette smoke activates innate immune cells by triggering pattern recognition receptors (PRRs) to release “danger signal”. These signals act as ligands to Toll-like receptors (TLRs), triggering the production of cytokines and inducing innate inflammation. In smokers who develop COPD there appears to be a specific pattern of inflammation in the airways and parenchyma as a result of both innate and adaptive immune responses, with the predominance of CD8+ and CD4+ cells, and in the more severe disease, with the presence of lymphoid follicles containing B lymphocytes and T cells. Furthermore, viral and bacterial infections interfere with the chronic inflammation seen in stable COPD and exacerbations via pathogen-associated molecular patterns (PAMPs). Finally, autoimmunity is another novel aspect that may play a critical role in the pathogenesis of COPD. This review is un update of the currently discussed roles of inflammatory and immune responses in the pathogenesis of COPD.
Từ khóa
Tài liệu tham khảo
2013, The European Respiratory Journal, 41, 1058
1994, The American Journal of Respiratory and Critical Care Medicine, 149, 803, 10.1164/ajrccm.149.3.7509705
1999, The American Journal of Respiratory and Critical Care Medicine, 160, S29
1995, The American Journal of Respiratory and Critical Care Medicine, 152, 1666, 10.1164/ajrccm.152.5.7582312
1998, The American Journal of Respiratory and Critical Care Medicine, 158, 1277, 10.1164/ajrccm.158.4.9802078
2002, The American Journal of Physiology—Lung Cellular and Molecular Physiology, 283, L867, 10.1152/ajplung.00020.2002
2008, Israel Medical Association Journal, 10, 837
2013, Respiratory Research, 1
2013, Medical Representative, 7, 499
2010, Proceedings of the British Pharmacological Socitey, 8, 149
2010, Monaldi Archives for Chest Disease, 73, 86
2012, Respiratory Research, 13
2012, The American Journal of Respiratory and Critical Care Medicine, 185, 1205, 10.1164/rccm.201108-1545OC
2013, The American Journal of Respiratory Cell and Molecular Biology, 48, 725, 10.1165/rcmb.2012-0173OC
1998, The American Journal of Respiratory and Critical Care Medicine, 157, 822, 10.1164/ajrccm.157.3.9709027
2013, Respiratory Research, 14
2013, The American Journal of Respiratory and Critical Care Medicine, 187, 1194, 10.1164/rccm.201208-1543OC
2011, The American Journal of Respiratory and Critical Care Medicine, 183, 1025, 10.1164/rccm.201001-0029OC
2012, PLoS One, 7
2012, The American Journal of Respiratory and Critical Care Medicine, 185, 1073, 10.1164/rccm.201111-2075OC
2012, PLoS One, 7
2011, PLoS One, 6